Pediatric neurosurgeon P. David Adelson, M.D., discusses partnership with Sephos AI on Autonomous Registry and Analytics ...
Psychological interventions may be effective for achieving freedom from functional seizures, according to new practice ...
A recent study points to a potential link between GLP-1 drugs and its ability to reduce risk of epilepsy in people with type 2 diabetes. GLP-1 drugs (semaglutide) are those which mimic the function of ...
AI-powered registries may improve epilepsy care by extracting data from incomplete medical records, easing the burden on clinicians when decisions are necessary regarding surgical evaluations, data ...
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...
Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...
Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...
Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...
Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says ...
Dr. Samuel Terman from the University of Michigan, who led the second study, said that people with both epilepsy and ...
Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results